UCM707, an inhibitor of the anandamide uptake, behaves as a symptom control agent in models of Huntington's disease and multiple sclerosis, but fails to delay/arrest the progression of different motor-related disorders.
| Image |  |
|---|---|
| Description | scientific article published on 11 July 2005 |
| Author/s |
author: Silvia Ortega-Gutiérrez Eva de Lago María L López-Rodríguez |
| Publication date | July 11, 2005 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |